Inventor

Michel Revel

Inventor

Rehovot, IL

Overview

40→

Patents

1981–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 40 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes27%

C07KPeptides21%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%

C12NMicroorganisms or enzymes13%

G01NInvestigating or analysing materials by determining their chemical or physical properties8%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests6%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms5%

A61BDiagnosis1%

C07CAcyclic or carbocyclic compounds1%

C07HSugars1%

PatentTitleYear

11,017,528Method and device for processing at least one image of a given part of at least one lung of a patient2021 10,258,651Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS2019 9,631,175'Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS'2017 9,404,087'Insulin producing cells derived from pluripotent stem cells'2016 8,809,052'Methods of generating mature oligodendrocytes'2014 8,617,887'Method of generating oligodendrocytes from neurosphere cells'2013 8,394,367'IL6R/IL6 chimera for therapy of chemotherapy-induced peripheral neuropathy'2013 7,824,670'Use of il6r/il6 chimera in nerve cell regeneration'2010 7,524,928'IFN receptor 1 binding proteins'2009 7,374,912'Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof'2008 7,264,945'IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons'2007 7,201,896'IL6RIL6 chimera for the treatment of neurodegenerative diseases'2007 7,198,781'Chimeric interleukin-6 soluble receptor/ligand proteins'2007 6,172,042'Synthetic peptides that inhibit IL-6 activity'2001 5,902,576'Antitumor pharmaceutical composition comprising IL-6 transfected cells'1999 5,763,210'Recombinant production of interferon-gamma binding proteins'1998 5,643,749'Soluble interferon .alpha.-receptor, its preparation and use'1997 5,621,077'Soluble IFN-.beta.2/IL-6 binding protein its preparation, and pharmaceutical compositions containing it'1997 5,618,700'IL-6 specific monoclonal antibodies, hybridomas therefor and methods of making and using same'1997 5,554,513'Production of recombinant human interferon-beta.sub.2'1996 5,554,514'Production of recombinant human interferon beta.sub.2.sbsb.B'1996 5,541,312'Production of interferon'1996 5,510,472'Production of recombinant human interferon-beta2'1996 5,468,608'Production of interferon'1995 5,468,609'Production of interferon'1995 5,468,607'Production of interferon'1995 5,462,731'Use of IL-6 for the treatment of chronic lymphocyte leukemia (CLL) and B-cell lymphomas'1995 5,358,867'DNA cloning and expression of an L7 protein which modulates the 2\'-5\' oligosynthetase and H2-K*K response to type-I interferon'1994 5,216,128'IFN-.beta.2/IL-6 receptor its preparation and pharmaceutical compositions containing it'1993 5,071,963'Interferon-induced human (2\'-5\') oligo A synthetase'1991 5,071,742'Assay for amoebae and probes for use therein'1991 5,063,159'Interferon-induced (2\'-5\') oligo a synthetase gene, mRNA, cDNA and enzymes having (2\'-5\') oligo a synthetase activity'1991 5,049,589'Antiviral aerosol compositions and pressurized containers containing same'1991 5,047,435'Antiviral compositions containing aromatic polycyclic diones and method for treating retrovirus infections'1991 4,898,891'Antiviral compositions'1990 4,889,803'Production of interferon gamma'1989 4,808,523'Constitutive production of human IFN-.beta.1 by mammalian cells transformed by the IFN-.beta.1 gene fused to an SV40 early promoter'1989 4,622,292'Assay and kit for determining interferon'1986 4,378,352'(2\'-5\')Oligo-isoadenylate pharmaceutical compositions and method of use'1983 4,302,533'Novel assays for interferon'1981

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1981–2019Patents assigned to YEDA RES & DEV (37)· patent assignee history

1981–2016Based in Rehovot, IL· patent location history

2013–2016Patents assigned to REVEL MICHEL (4)· patent assignee history

2013–2016Patents assigned to CHEBATH JUDITH (3)· patent assignee history

2014–2016Patents assigned to IZRAEL MICHAL (2)· patent assignee history

2014–2016Patents assigned to KAUFMAN ROSALIA (2)· patent assignee history

2014–2019Based in Rechovot, IL· patent location history

2021Based in Paris, FR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
YEDA RES & DEV	37	1981–2019
REVEL MICHELself	4	2013–2016
CHEBATH JUDITH	3	2013–2016
IZRAEL MICHAL	2	2014–2016
KAUFMAN ROSALIA	2	2014–2016

Locations

Location	Patents	Span
Rehovot, IL	36	1981–2016
Rechovot, IL	3	2014–2019
Paris, FR	1	2021